TOP TIERMARKET NEWSWIRE
News & sentiment

ARCUTIS BIOTHERAPEUT (ARQT) — News & AI sentiment

ARCUTIS BIOTHERAPEUT (ARQT) news roundup. 1 story in the last 24 hours, 3 in the past week, 21 over 30 days. Average 24-hour sentiment is 52/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 11 sales totalling $2.1M — net selling of $2.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 52/100
7d stories
3
avg sentiment 50.7/100
30d stories
21
avg sentiment 58.1/100
Insider net (90d)
$2.1M
0 buys · 11 sells
Congress (90d)
0
0 buys · 0 sells

ARQT news in the last 24 hours, 7 days, 30 days and 90 days

How much ARQT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowARQT storiesAvg AI sentimentRead
Last 24 hours152/100ARQT headlines →
Last 7 days350.7/100ARQT headlines →
Last 30 days2158.1/100ARQT headlines →
Last 90 days4158/100ARQT headlines →

Latest stories on ARQT

20h ago
7d ago
7d ago
Oct 19
Oct 19
Oct 15
Oct 15
Oct 9
Oct 9
Oct 9
Oct 9
Arcutis Biotherapeutics: An Emerging GARP Stock
Seeking Alpha73 · bullishanalyst
Oct 6
Oct 6
Oct 6
Oct 5
Oct 2
Oct 2
Oct 2
Sep 29
Sep 29
Sep 29
Sep 16
Arcutis Biotherapeutics rises 7.7%
The Fly56 · neutralgeneral
Sep 16
Sep 4
Sep 4
Open ARQT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →